Caledonia, NY, United States of America

John Charles Gordon


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: John Charles Gordon: Innovator in Spiro-Azabicyclic Compounds

Introduction

John Charles Gordon is a notable inventor based in Caledonia, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on spiro-azabicyclic compounds. With a total of two patents to his name, Gordon's inventions are aimed at addressing critical health issues.

Latest Patents

Gordon's latest patents include the development of spiro-azabicyclic compounds that are useful in therapy. These compounds are represented by a specific formula, wherein R can be hydrogen or methyl, and n can be either 1 or 2. The patents detail processes for preparing these compounds, compositions containing them, and their therapeutic uses. The compounds are expected to be beneficial in treating psychotic disorders, intellectual impairment disorders, and anxiety.

Career Highlights

Throughout his career, John Charles Gordon has worked with prominent companies in the pharmaceutical industry, including Astra AB and Astra Aktiebolag. His work has contributed to advancements in therapeutic compounds that have the potential to improve the quality of life for many individuals.

Collaborations

Gordon has collaborated with notable coworkers such as Ronald C. Griffith and Robert John Murray. Their combined expertise has likely played a role in the successful development of his patented compounds.

Conclusion

John Charles Gordon's innovative work in the field of spiro-azabicyclic compounds showcases his commitment to advancing therapeutic solutions. His contributions are expected to have a lasting impact on the treatment of various mental health disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…